Review: In VTE, reduced- and full-dose extended DOAC therapies do not differ and are better than no extended therapy

L. Vasanthamohan, Thomas DeLoughery

    Research output: Contribution to journalComment/debatepeer-review

    Original languageEnglish (US)
    Pages (from-to)JC52
    JournalAnnals of internal medicine
    Issue number10
    StatePublished - Nov 20 2018

    ASJC Scopus subject areas

    • Internal Medicine

    Cite this